Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden

Scand J Infect Dis. 1998;30(1):5-10. doi: 10.1080/003655498750002222.


The objective of the study was to evaluate the economic consequences of a general childhood vaccination programme against Haemophilus influenzae type b (Hib) in Sweden. A retrospective pre-vaccination annual cohort of 0-4-y-old children was compared with an annual cohort of the same age group after a complete implemented vaccination program against Hib. The cost analysis shows that vaccination against Hib is cost saving when indirect costs are included in the analysis. In the cost-benefit analysis it is shown that society will gain approximately 88 million Swedish Crowns (SEK) annually when Hib vaccination is totally implemented. In conclusion, general childhood Hib vaccination is a cost-effective public health intervention in Swedish society.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Cost-Benefit Analysis
  • Haemophilus Infections / economics
  • Haemophilus Infections / prevention & control*
  • Haemophilus Vaccines* / economics
  • Haemophilus influenzae type b / immunology
  • Humans
  • Infant
  • Sweden
  • Vaccination / economics*


  • Haemophilus Vaccines